The United States Provides 2.2 Million Additional Doses of Pfizer’s Coronavirus Vaccine to Egypt

February 20, 2022

U.S. Coronavirus Vaccine Deliveries to Egypt Reach 23.5 Million Doses    

Cairo – On February 20, the United States delivered 2.2 million doses of Pfizer’s coronavirus vaccine to Egypt as part of its global campaign to defeat COVID-19.  The delivery marks the latest milestone in U.S.-Egypt joint efforts to fight the virus.  To date, the United States has delivered 23.5 million doses of the vaccine to Egypt—more than all other countries in the Middle East and North Africa combined—and encourages all eligible Egyptians to get vaccinated.  

Highlighting the importance of cooperation in defeating the pandemic, U.S. Secretary of State Antony Blinken stated, “A global problem requires a global solution.  No one country acting alone can stop the virus.”

The U.S. Government, through USAID, has provided more than $55 million (864 million EGP)—reaching 18 million people—in support of Egypt’s coronavirus response.  USAID programs train healthcare workers, boost small businesses, improve tracking of the virus, and deliver vaccines to the Egyptian people.  This support builds on the more than $1 billion (15.7 billion EGP) the United States has invested in Egypt over the past 40 years to improve healthcare outcomes in Egypt.